The Flaws in the Patent System

This chapter explores the flaws in the current patent system, particularly in the pharmaceutical industry, leading to escalating drug prices and limited access to essential medications for many. The conversation emphasizes the need for reforms to transition towards a more balanced system that prioritizes public interest over corporate profits. Various case studies and suggestions for improvement are discussed, highlighting the urgency of addressing these critical issues.